Are primary care physicians, public and private sector specialists substitutes or complements? Evidence from a simultaneous equations model for count data

Journal of Health Economics
Vincenzo Atella, Partha Deb

Abstract

In this paper, we examine the relationships between health care visits to general practitioners, public and private sector specialists using data from Italy, which has a mixed public-private health care system. We develop a simultaneous equations model that allows for the discreteness of measures of utilization and estimate this model using maximum simulated likelihood. Once common unobserved heterogeneity is properly accounted for, general practitioners, public and private specialists are found to be substitute sources of medical care. In contrast, a naive model finds they are complements.

References

Feb 24, 2001·Journal of Health Economics·C Propper

❮ Previous
Next ❯

Citations

Jan 13, 2009·Journal of Health Economics·Daniele Fabbri, Chiara Monfardini
Aug 12, 2008·Journal of Health Economics·Angel López Nicolás, Marcos Vera-Hernández
Aug 1, 2009·Health Economics·Anthony ScottPeter Sivey
May 23, 2012·Health Policy·Martin GächterHannes Winner
Dec 30, 2014·Journal of Health Economics·Geir GodagerChing-to Albert Ma
Aug 23, 2005·Lancet·Benjamin Loevinsohn, April Harding
Oct 16, 2016·Health Economics·M Kamrul Islam, Egil Kjerstad
Nov 16, 2014·Archives of Disease in Childhood·Ruth BakerDenise Kendrick
Oct 6, 2017·Health Policy and Planning·Asankha Pallegedara, Michael Grimm
Jan 18, 2017·Health Economics Review·Tugba BüyükdurmusHarald Tauchmann

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.